Browse by People

Wong, SPY, Huda, M, English, P, Bargiota, A, Wilding, JPH ORCID: 0000-0003-2839-8404, Johnson, A, Corrall, R and Pinkney, JH (2019) Adipokines and the insulin resistance syndrome in familial partial lipodystrophy caused by a mutation in lamin A/C (vol 48, pg 2641, 2005). DIABETOLOGIA, 62 (4). p. 732.

Collapse authors list.
Ashrafi, R, Modi, P, Oo, AY, Pullan, DM, Jian, K, Zhang, H, Gerges, J Yanni, Hart, G, Boyett, MR, Davis, GK et al (show 1 more authors) and Wilding, JPH ORCID: 0000-0003-2839-8404 (2017) Arrhythmogenic gene remodelling in elderly patients with type 2 diabetes with aortic stenosis and normal left ventricular ejection fraction. EXPERIMENTAL PHYSIOLOGY, 102 (11). pp. 1424-1434.

Wilding, JPH ORCID: 0000-0003-2839-8404 (2018) Beyond lifestyle interventions: exploring the potential of anti-obesity medications in the UK. CLINICAL OBESITY, 8 (3). pp. 211-225.

Collapse authors list.
Wilding, JPH ORCID: 0000-0003-2839-8404, Godec, T, Khunti, K, Pocock, S, Fox, R, Smeeth, L, Blak, B, Clauson, P, Fenici, P, Hammar, N et al (show 2 more authors) , Rigney, U and Medina, J (2017) Changes in HbA_1c and weight after initiation of second-line therapy in patients with type 2 diabetes in clinical practice. .

Ashrafi, R (2016) DIABETES AND OBESITY: EVIDENCE FOR A CARDIOMYOPATHY. PhD thesis, University of Liverpool.

Collapse authors list.
Wiviott, SD, Raz, I, Bonaca, MP, Mosenzon, O, Kato, ET, Cahn, A, Silverman, MG, Zelniker, TA, Kuder, JF, Murphy, SA et al (show 10 more authors) , Bhatt, DL, Leiter, LA, McGuire, DK, Wilding, JPH ORCID: 0000-0003-2839-8404, Ruff, CT, Gause-Nilsson, IAM, Fredriksson, M, Johansson, PA, Langkilde, A-M and Sabatine, MS (2019) Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. NEW ENGLAND JOURNAL OF MEDICINE, 380 (4). pp. 347-357.

Le Roux, CW, Lau, DCW, Fujioka, K, Greenway, F, Wilding, JPH ORCID: 0000-0003-2839-8404, Jacobsen, PB, Skjoth, T and Madsbad, S (2017) Early weight loss responders to liraglutide 3.0mg had greater weight loss, regression to normoglycaemia, and reduced Type 2 diabetes development at three years vs early non-responders: SCALE Obesity and Prediabetes. .

Collapse authors list.
Zelniker, TA, Raz, I, Mosenzon, O, Dwyer, JP, Heerspink, HJL, Cahn, A, Im, K, Bhatt, DL, Leiter, LA, McGuire, DK et al (show 5 more authors) , Wilding, JPH ORCID: 0000-0003-2839-8404, Gause-Nilsson, IAM, Langkilde, AM, Sabatine, MS and Wiviott, SD (2019) Effect of dapagliflozin on cardiovascular outcomes in patients with type 2 diabetes according to baseline renal function and albuminuria status: Insights from DECLARE-TIMI 58. .

Steele, T, Narayanan, RP, James, M, James, J, Mazey, N and Wilding, JPH ORCID: 0000-0003-2839-8404 (2017) Evaluation of Aintree LOSS, a community-based, multidisciplinary weight management service: outcomes and predictors of engagement. CLINICAL OBESITY, 7 (6). pp. 368-376.

Wilding, JPH ORCID: 0000-0003-2839-8404, Overgaard, RV, Jacobsen, LV, Jensen, CB and le Roux, CW (2016) Exposure-response analyses of liraglutide 3.0 mg for weight management. Diabetes, Obesity and Metabolism: a journal of pharmacology and therapeutics, 18 (5). pp. 491-499.

Collapse authors list.
Narayanan, RP, Weeks, AD ORCID: 0000-0002-1909-337X, Quenby, S, Rycroft, D, Hart, A, Longworth, H, Charnley, M, Abayomi, J, Topping, J, Turner, MA ORCID: 0000-0002-5299-8656 et al (show 1 more authors) and Wilding, JPH ORCID: 0000-0003-2839-8404 (2016) Fit for Birth - the effect of weight changes in obese pregnant women on maternal and neonatal outcomes: a pilot prospective cohort study. CLINICAL OBESITY, 6 (1). pp. 79-88.

Wilding, JPH ORCID: 0000-0003-2839-8404, Fujioka, K, Greenway, F, Lau, DCW, O'Neil, P, Jacobsen, PB, Skjoth, TV and Madsbad, S (2016) Greater weight loss and regression to normoglycaemia, and reduced risk of T2D, at 3 years in early weight loss responders to liraglutide 3.0 mg vs early non-responders. In: European Association for the Study of Diabetes, 2016-9-11 - 2016-9-15.

Davies, KA Bowden, Sprung, VS ORCID: 0000-0002-2666-4986, Norman, JA, Wilding, JPH ORCID: 0000-0003-2839-8404, Kemp, GJ and Cuthbertson, DJ (2017) Implementing a step reduction model to examine the metabolic effects of physical inactivity. .

Al-Bazz, DY and Wilding, JPH ORCID: 0000-0003-2839-8404 (2020) Is the latest evidence for cardiovascular protection with glucose-lowering medicines being implemented in clinical practice? .

Aditya, B (2016) Mechanisms underlying diabetes remission after weight loss surgery for morbid obesity: energy restriction, weight loss, gut hormones or adipokines? Doctor of Medicine thesis, University of Liverpool.

Hydes, TJ ORCID: 0000-0002-7768-6886, Summers, N, Brown, E, Alam, U ORCID: 0000-0002-3190-1122, Thomaides-Brears, H, Wilding, JPH ORCID: 0000-0003-2839-8404 and Cuthbertson, DJ ORCID: 0000-0002-6128-0822 (2020) Mechanisms, screening modalities and treatment options for individuals with non‐alcoholic fatty liver disease and type 2 diabetes. Diabetic Medicine, 37 (11). pp. 1793-1806.

Sprung, VS ORCID: 0000-0002-2666-4986, Davies, KA Bowden, Norman, JA, Thompson, A ORCID: 0000-0002-7087-9415, Wilding, JPH ORCID: 0000-0003-2839-8404, Jones, H, Kemp, GJ and Cuthbertson, DJ (2018) Metabolically healthy and unhealthy obesity: Metabolic health status rather than obesity is a more accurate prognostic marker for cardiovascular health. .

Bray, GA, Kim, KK and Wilding, JPH ORCID: 0000-0003-2839-8404 (2017) Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. OBESITY REVIEWS, 18 (7). pp. 715-723.

Lim, JZM, Burgess, J ORCID: 0000-0002-7165-6918, Ooi, CG, Ponirakis, G, Malik, RA, Wilding, JPH ORCID: 0000-0003-2839-8404 and Alam, Uazman ORCID: 0000-0002-3190-1122 (2022) The Peripheral Neuropathy Prevalence and Characteristics Are Comparable in People with Obesity and Long-Duration Type 1 Diabetes. Advances in Therapy, 39 (9). pp. 4218-4229.

Wilding, JPH ORCID: 0000-0003-2839-8404 and Bain, SC (2016) Role of incretin-based therapies and sodium-glucose co-transporter-2 inhibitors as adjuncts to insulin therapy in Type 2 diabetes, with special reference to IDegLira. DIABETIC MEDICINE, 33 (7). pp. 864-876.

Collapse authors list.
Davies, MJ, Baldry, EL, Bodicoat, DH, Chatterjee, S, Edwardson, CL, Gray, LJ, Khunti, K, Sargeant, JA, Stensel, DJ, Webb, DR et al (show 4 more authors) , Wilding, JPH ORCID: 0000-0003-2839-8404, Willis, SA, Yates, T and King, JA (2020) The SGLT2 inhibitor empagliflozin does not stimulate compensatory appetite responses in patients with excess adiposity and type 2 diabetes. .

Collapse authors list.
Longworth, H, McCallin, K, Narayanan, RP, Turner, MA ORCID: 0000-0002-5299-8656, Quenby, S, Rycroft, D, Charnley, M, Abayomi, J, Topping, J, Weeks, AD ORCID: 0000-0002-1909-337X et al (show 1 more authors) and Wilding, JPH ORCID: 0000-0003-2839-8404 (2017) Screening methods for obstructive sleep apnoea in severely obese pregnant women. CLINICAL OBESITY, 7 (4). pp. 239-244.

Wilding, JPH ORCID: 0000-0003-2839-8404, Kwan, AYM, Maldonado, JM, Wang, H and Rasouli, N (2022) Tirzepatide induces weight loss in patients with type 2 diabetes regardless of baseline BMI: a post hoc analysis of SURPASS-1 through SURPASS-5 studies. .

Nair, S (2016) Variability in Creatinine and Estimated Glomerular Filtration Rate in diabetic nephropathy. PhD thesis, University of Liverpool.

Wilding, JPH ORCID: 0000-0003-2839-8404, Rodbard, HW, Uusinarkaus, KT, Van Gaal, L, Hansen, T, Sandberg, AML, Tadayon, S and Davies, MJ (2019) Weight loss induced by semaglutide once weekly contributes to improved health-related quality of life and treatment satisfaction. .

Zhu, J (2017) The anti-inflammatory effects of vitamin D receptor agonists on human white preadipocytes. PhD thesis, University of Liverpool.

Wilding, JPH ORCID: 0000-0003-2839-8404, Sharma, AM, Finer, N, Padwal, RS, Skjoth, T, Jensen, CB and Kushner, R (2017) The efficacy and safety of liraglutide 3.0mg for weight management are similar across baseline Edmonton Obesity Staging System (EOSS) categories: post-hoc analysis at 56 weeks. .